0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Eluting Coronary Stent System Market Research Report 2026
Published Date: 2026-01-26
|
Report Code: QYRE-Auto-28G15196
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Drug Eluting Coronary Stent System Market Research Report 2023
BUY CHAPTERS

Global Drug Eluting Coronary Stent System Market Research Report 2026

Code: QYRE-Auto-28G15196
Report
2026-01-26
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Eluting Coronary Stent System Market Size

The global Drug Eluting Coronary Stent System market was valued at US$ 6191 million in 2025 and is anticipated to reach US$ 8252 million by 2032, at a CAGR of 4.3% from 2026 to 2032.

Drug Eluting Coronary Stent System Market

Drug Eluting Coronary Stent System Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drug Eluting Coronary Stent System competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The drug-eluting coronary stent system is a medical device used to treat coronary artery disease. It slowly releases drugs by coating the stent surface with a drug coating to inhibit intimal hyperplasia and reduce the occurrence of restenosis. Compared with bare metal stents, drug-eluting coronary stents have lower restenosis rates and better long-term effects.
The North American market for Drug Eluting Coronary Stent System is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Drug Eluting Coronary Stent System is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Drug Eluting Coronary Stent System include Boston Scientific, Medtronic, Abbott, B.Braun, BD, Biotronik AG, Stentys SA, Sino Medical, Beijing ESSEN Technology, Beijing Advanced Medical Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Drug Eluting Coronary Stent System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug Eluting Coronary Stent System. The Drug Eluting Coronary Stent System market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drug Eluting Coronary Stent System market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drug Eluting Coronary Stent System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Drug Eluting Coronary Stent System Market Report

Report Metric Details
Report Name Drug Eluting Coronary Stent System Market
Accounted market size in 2025 US$ 6191 million
Forecasted market size in 2032 US$ 8252 million
CAGR 4.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Rapamycin Eluting Stent
  • Everolimus Eluting Stent
  • Others
by Application
  • Hospitals
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boston Scientific, Medtronic, Abbott, B.Braun, BD, Biotronik AG, Stentys SA, Sino Medical, Beijing ESSEN Technology, Beijing Advanced Medical Technologies, LifeTech Scientific Corporation, MicroPort Scientific Corporation, Yilson Medical Technology, Lepu Medical Technology, Shandong Hua'an Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Drug Eluting Coronary Stent System manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Drug Eluting Coronary Stent System sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Drug Eluting Coronary Stent System Market growing?

Ans: The Drug Eluting Coronary Stent System Market witnessing a CAGR of 4.3% during the forecast period 2026-2032.

What is the Drug Eluting Coronary Stent System Market size in 2032?

Ans: The Drug Eluting Coronary Stent System Market size in 2032 will be US$ 8252 million.

Who are the main players in the Drug Eluting Coronary Stent System Market report?

Ans: The main players in the Drug Eluting Coronary Stent System Market are Boston Scientific, Medtronic, Abbott, B.Braun, BD, Biotronik AG, Stentys SA, Sino Medical, Beijing ESSEN Technology, Beijing Advanced Medical Technologies, LifeTech Scientific Corporation, MicroPort Scientific Corporation, Yilson Medical Technology, Lepu Medical Technology, Shandong Hua'an Biotechnology

What are the Application segmentation covered in the Drug Eluting Coronary Stent System Market report?

Ans: The Applications covered in the Drug Eluting Coronary Stent System Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Drug Eluting Coronary Stent System Market report?

Ans: The Types covered in the Drug Eluting Coronary Stent System Market report are Rapamycin Eluting Stent, Everolimus Eluting Stent, Others

1 Drug Eluting Coronary Stent System Market Overview
1.1 Product Definition
1.2 Drug Eluting Coronary Stent System by Type
1.2.1 Global Drug Eluting Coronary Stent System Market Value by Type: 2025 vs 2032
1.2.2 Rapamycin Eluting Stent
1.2.3 Everolimus Eluting Stent
1.2.4 Others
1.3 Drug Eluting Coronary Stent System by Application
1.3.1 Global Drug Eluting Coronary Stent System Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global Drug Eluting Coronary Stent System Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Coronary Stent System Revenue 2021–2032
1.4.2 Global Drug Eluting Coronary Stent System Sales 2021–2032
1.4.3 Global Drug Eluting Coronary Stent System Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Drug Eluting Coronary Stent System Market Competition by Manufacturers
2.1 Global Drug Eluting Coronary Stent System Sales Market Share by Manufacturers (2021–2026)
2.2 Global Drug Eluting Coronary Stent System Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Drug Eluting Coronary Stent System Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Drug Eluting Coronary Stent System, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Drug Eluting Coronary Stent System, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Drug Eluting Coronary Stent System, Product Types and Applications
2.7 Global Key Manufacturers of Drug Eluting Coronary Stent System, Date of Entry into the Industry
2.8 Global Drug Eluting Coronary Stent System Market Competitive Situation and Trends
2.8.1 Global Drug Eluting Coronary Stent System Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Drug Eluting Coronary Stent System Players Market Share by Revenue
2.8.3 Global Drug Eluting Coronary Stent System Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Eluting Coronary Stent System Market Scenario by Region
3.1 Global Drug Eluting Coronary Stent System Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Drug Eluting Coronary Stent System Sales by Region: 2021–2032
3.2.1 Global Drug Eluting Coronary Stent System Sales by Region: 2021–2026
3.2.2 Global Drug Eluting Coronary Stent System Sales by Region: 2027–2032
3.3 Global Drug Eluting Coronary Stent System Revenue by Region: 2021–2032
3.3.1 Global Drug Eluting Coronary Stent System Revenue by Region: 2021–2026
3.3.2 Global Drug Eluting Coronary Stent System Revenue by Region: 2027–2032
3.4 North America Drug Eluting Coronary Stent System Market Facts & Figures by Country
3.4.1 North America Drug Eluting Coronary Stent System Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Drug Eluting Coronary Stent System Sales by Country (2021–2032)
3.4.3 North America Drug Eluting Coronary Stent System Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Coronary Stent System Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Coronary Stent System Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Drug Eluting Coronary Stent System Sales by Country (2021–2032)
3.5.3 Europe Drug Eluting Coronary Stent System Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Coronary Stent System Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Eluting Coronary Stent System Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Drug Eluting Coronary Stent System Sales by Region (2021–2032)
3.6.3 Asia Pacific Drug Eluting Coronary Stent System Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Eluting Coronary Stent System Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Coronary Stent System Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Drug Eluting Coronary Stent System Sales by Country (2021–2032)
3.7.3 Latin America Drug Eluting Coronary Stent System Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drug Eluting Coronary Stent System Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Coronary Stent System Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Drug Eluting Coronary Stent System Sales by Country (2021–2032)
3.8.3 Middle East and Africa Drug Eluting Coronary Stent System Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Coronary Stent System Sales by Type (2021–2032)
4.1.1 Global Drug Eluting Coronary Stent System Sales by Type (2021–2026)
4.1.2 Global Drug Eluting Coronary Stent System Sales by Type (2027–2032)
4.1.3 Global Drug Eluting Coronary Stent System Sales Market Share by Type (2021–2032)
4.2 Global Drug Eluting Coronary Stent System Revenue by Type (2021–2032)
4.2.1 Global Drug Eluting Coronary Stent System Revenue by Type (2021–2026)
4.2.2 Global Drug Eluting Coronary Stent System Revenue by Type (2027–2032)
4.2.3 Global Drug Eluting Coronary Stent System Revenue Market Share by Type (2021–2032)
4.3 Global Drug Eluting Coronary Stent System Price by Type (2021–2032)
5 Segment by Application
5.1 Global Drug Eluting Coronary Stent System Sales by Application (2021–2032)
5.1.1 Global Drug Eluting Coronary Stent System Sales by Application (2021–2026)
5.1.2 Global Drug Eluting Coronary Stent System Sales by Application (2027–2032)
5.1.3 Global Drug Eluting Coronary Stent System Sales Market Share by Application (2021–2032)
5.2 Global Drug Eluting Coronary Stent System Revenue by Application (2021–2032)
5.2.1 Global Drug Eluting Coronary Stent System Revenue by Application (2021–2026)
5.2.2 Global Drug Eluting Coronary Stent System Revenue by Application (2027–2032)
5.2.3 Global Drug Eluting Coronary Stent System Revenue Market Share by Application (2021–2032)
5.3 Global Drug Eluting Coronary Stent System Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boston Scientific Drug Eluting Coronary Stent System Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Medtronic Drug Eluting Coronary Stent System Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abbott Drug Eluting Coronary Stent System Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 B.Braun
6.4.1 B.Braun Company Information
6.4.2 B.Braun Description and Business Overview
6.4.3 B.Braun Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 B.Braun Drug Eluting Coronary Stent System Product Portfolio
6.4.5 B.Braun Recent Developments/Updates
6.5 BD
6.5.1 BD Company Information
6.5.2 BD Description and Business Overview
6.5.3 BD Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BD Drug Eluting Coronary Stent System Product Portfolio
6.5.5 BD Recent Developments/Updates
6.6 Biotronik AG
6.6.1 Biotronik AG Company Information
6.6.2 Biotronik AG Description and Business Overview
6.6.3 Biotronik AG Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Biotronik AG Drug Eluting Coronary Stent System Product Portfolio
6.6.5 Biotronik AG Recent Developments/Updates
6.7 Stentys SA
6.7.1 Stentys SA Company Information
6.7.2 Stentys SA Description and Business Overview
6.7.3 Stentys SA Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Stentys SA Drug Eluting Coronary Stent System Product Portfolio
6.7.5 Stentys SA Recent Developments/Updates
6.8 Sino Medical
6.8.1 Sino Medical Company Information
6.8.2 Sino Medical Description and Business Overview
6.8.3 Sino Medical Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sino Medical Drug Eluting Coronary Stent System Product Portfolio
6.8.5 Sino Medical Recent Developments/Updates
6.9 Beijing ESSEN Technology
6.9.1 Beijing ESSEN Technology Company Information
6.9.2 Beijing ESSEN Technology Description and Business Overview
6.9.3 Beijing ESSEN Technology Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Beijing ESSEN Technology Drug Eluting Coronary Stent System Product Portfolio
6.9.5 Beijing ESSEN Technology Recent Developments/Updates
6.10 Beijing Advanced Medical Technologies
6.10.1 Beijing Advanced Medical Technologies Company Information
6.10.2 Beijing Advanced Medical Technologies Description and Business Overview
6.10.3 Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Product Portfolio
6.10.5 Beijing Advanced Medical Technologies Recent Developments/Updates
6.11 LifeTech Scientific Corporation
6.11.1 LifeTech Scientific Corporation Company Information
6.11.2 LifeTech Scientific Corporation Description and Business Overview
6.11.3 LifeTech Scientific Corporation Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 LifeTech Scientific Corporation Drug Eluting Coronary Stent System Product Portfolio
6.11.5 LifeTech Scientific Corporation Recent Developments/Updates
6.12 MicroPort Scientific Corporation
6.12.1 MicroPort Scientific Corporation Company Information
6.12.2 MicroPort Scientific Corporation Description and Business Overview
6.12.3 MicroPort Scientific Corporation Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 MicroPort Scientific Corporation Drug Eluting Coronary Stent System Product Portfolio
6.12.5 MicroPort Scientific Corporation Recent Developments/Updates
6.13 Yilson Medical Technology
6.13.1 Yilson Medical Technology Company Information
6.13.2 Yilson Medical Technology Description and Business Overview
6.13.3 Yilson Medical Technology Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Yilson Medical Technology Drug Eluting Coronary Stent System Product Portfolio
6.13.5 Yilson Medical Technology Recent Developments/Updates
6.14 Lepu Medical Technology
6.14.1 Lepu Medical Technology Company Information
6.14.2 Lepu Medical Technology Description and Business Overview
6.14.3 Lepu Medical Technology Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Lepu Medical Technology Drug Eluting Coronary Stent System Product Portfolio
6.14.5 Lepu Medical Technology Recent Developments/Updates
6.15 Shandong Hua'an Biotechnology
6.15.1 Shandong Hua'an Biotechnology Company Information
6.15.2 Shandong Hua'an Biotechnology Description and Business Overview
6.15.3 Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Product Portfolio
6.15.5 Shandong Hua'an Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Coronary Stent System Industry Chain Analysis
7.2 Drug Eluting Coronary Stent System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Coronary Stent System Production Mode & Process Analysis
7.4 Drug Eluting Coronary Stent System Sales and Marketing
7.4.1 Drug Eluting Coronary Stent System Sales Channels
7.4.2 Drug Eluting Coronary Stent System Distributors
7.5 Drug Eluting Coronary Stent System Customer Analysis
8 Drug Eluting Coronary Stent System Market Dynamics
8.1 Drug Eluting Coronary Stent System Industry Trends
8.2 Drug Eluting Coronary Stent System Market Drivers
8.3 Drug Eluting Coronary Stent System Market Challenges
8.4 Drug Eluting Coronary Stent System Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Drug Eluting Coronary Stent System Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Drug Eluting Coronary Stent System Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Drug Eluting Coronary Stent System Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Drug Eluting Coronary Stent System Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Drug Eluting Coronary Stent System Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Drug Eluting Coronary Stent System Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Drug Eluting Coronary Stent System Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Drug Eluting Coronary Stent System Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Drug Eluting Coronary Stent System, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Drug Eluting Coronary Stent System, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Drug Eluting Coronary Stent System, Product Types and Applications
 Table 12. Global Key Manufacturers of Drug Eluting Coronary Stent System, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug Eluting Coronary Stent System Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drug Eluting Coronary Stent System Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug Eluting Coronary Stent System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Drug Eluting Coronary Stent System Sales by Region (K Units), 2021–2026
 Table 18. Global Drug Eluting Coronary Stent System Sales Market Share by Region (2021–2026)
 Table 19. Global Drug Eluting Coronary Stent System Sales by Region (K Units), 2027–2032
 Table 20. Global Drug Eluting Coronary Stent System Sales Market Share by Region (2027–2032)
 Table 21. Global Drug Eluting Coronary Stent System Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Drug Eluting Coronary Stent System Revenue Market Share by Region (2021–2026)
 Table 23. Global Drug Eluting Coronary Stent System Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Drug Eluting Coronary Stent System Revenue Market Share by Region (2027–2032)
 Table 25. North America Drug Eluting Coronary Stent System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Drug Eluting Coronary Stent System Sales by Country (K Units), 2021–2026
 Table 27. North America Drug Eluting Coronary Stent System Sales by Country (K Units), 2027–2032
 Table 28. North America Drug Eluting Coronary Stent System Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Drug Eluting Coronary Stent System Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Drug Eluting Coronary Stent System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Drug Eluting Coronary Stent System Sales by Country (K Units), 2021–2026
 Table 32. Europe Drug Eluting Coronary Stent System Sales by Country (K Units), 2027–2032
 Table 33. Europe Drug Eluting Coronary Stent System Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Drug Eluting Coronary Stent System Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Drug Eluting Coronary Stent System Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Drug Eluting Coronary Stent System Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Drug Eluting Coronary Stent System Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Drug Eluting Coronary Stent System Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Drug Eluting Coronary Stent System Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Drug Eluting Coronary Stent System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Drug Eluting Coronary Stent System Sales by Country (K Units), 2021–2026
 Table 42. Latin America Drug Eluting Coronary Stent System Sales by Country (K Units), 2027–2032
 Table 43. Latin America Drug Eluting Coronary Stent System Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Drug Eluting Coronary Stent System Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Drug Eluting Coronary Stent System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Drug Eluting Coronary Stent System Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Drug Eluting Coronary Stent System Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Drug Eluting Coronary Stent System Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Drug Eluting Coronary Stent System Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Drug Eluting Coronary Stent System Sales (K Units) by Type (2021–2026)
 Table 51. Global Drug Eluting Coronary Stent System Sales (K Units) by Type (2027–2032)
 Table 52. Global Drug Eluting Coronary Stent System Sales Market Share by Type (2021–2026)
 Table 53. Global Drug Eluting Coronary Stent System Sales Market Share by Type (2027–2032)
 Table 54. Global Drug Eluting Coronary Stent System Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Drug Eluting Coronary Stent System Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Drug Eluting Coronary Stent System Revenue Market Share by Type (2021–2026)
 Table 57. Global Drug Eluting Coronary Stent System Revenue Market Share by Type (2027–2032)
 Table 58. Global Drug Eluting Coronary Stent System Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Drug Eluting Coronary Stent System Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Drug Eluting Coronary Stent System Sales (K Units) by Application (2021–2026)
 Table 61. Global Drug Eluting Coronary Stent System Sales (K Units) by Application (2027–2032)
 Table 62. Global Drug Eluting Coronary Stent System Sales Market Share by Application (2021–2026)
 Table 63. Global Drug Eluting Coronary Stent System Sales Market Share by Application (2027–2032)
 Table 64. Global Drug Eluting Coronary Stent System Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Drug Eluting Coronary Stent System Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Drug Eluting Coronary Stent System Revenue Market Share by Application (2021–2026)
 Table 67. Global Drug Eluting Coronary Stent System Revenue Market Share by Application (2027–2032)
 Table 68. Global Drug Eluting Coronary Stent System Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Drug Eluting Coronary Stent System Price (US$/Unit) by Application (2027–2032)
 Table 70. Boston Scientific Company Information
 Table 71. Boston Scientific Description and Business Overview
 Table 72. Boston Scientific Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Boston Scientific Drug Eluting Coronary Stent System Product
 Table 74. Boston Scientific Recent Developments/Updates
 Table 75. Medtronic Company Information
 Table 76. Medtronic Description and Business Overview
 Table 77. Medtronic Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Medtronic Drug Eluting Coronary Stent System Product
 Table 79. Medtronic Recent Developments/Updates
 Table 80. Abbott Company Information
 Table 81. Abbott Description and Business Overview
 Table 82. Abbott Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Abbott Drug Eluting Coronary Stent System Product
 Table 84. Abbott Recent Developments/Updates
 Table 85. B.Braun Company Information
 Table 86. B.Braun Description and Business Overview
 Table 87. B.Braun Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. B.Braun Drug Eluting Coronary Stent System Product
 Table 89. B.Braun Recent Developments/Updates
 Table 90. BD Company Information
 Table 91. BD Description and Business Overview
 Table 92. BD Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. BD Drug Eluting Coronary Stent System Product
 Table 94. BD Recent Developments/Updates
 Table 95. Biotronik AG Company Information
 Table 96. Biotronik AG Description and Business Overview
 Table 97. Biotronik AG Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Biotronik AG Drug Eluting Coronary Stent System Product
 Table 99. Biotronik AG Recent Developments/Updates
 Table 100. Stentys SA Company Information
 Table 101. Stentys SA Description and Business Overview
 Table 102. Stentys SA Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Stentys SA Drug Eluting Coronary Stent System Product
 Table 104. Stentys SA Recent Developments/Updates
 Table 105. Sino Medical Company Information
 Table 106. Sino Medical Description and Business Overview
 Table 107. Sino Medical Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Sino Medical Drug Eluting Coronary Stent System Product
 Table 109. Sino Medical Recent Developments/Updates
 Table 110. Beijing ESSEN Technology Company Information
 Table 111. Beijing ESSEN Technology Description and Business Overview
 Table 112. Beijing ESSEN Technology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Beijing ESSEN Technology Drug Eluting Coronary Stent System Product
 Table 114. Beijing ESSEN Technology Recent Developments/Updates
 Table 115. Beijing Advanced Medical Technologies Company Information
 Table 116. Beijing Advanced Medical Technologies Description and Business Overview
 Table 117. Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Beijing Advanced Medical Technologies Drug Eluting Coronary Stent System Product
 Table 119. Beijing Advanced Medical Technologies Recent Developments/Updates
 Table 120. LifeTech Scientific Corporation Company Information
 Table 121. LifeTech Scientific Corporation Description and Business Overview
 Table 122. LifeTech Scientific Corporation Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. LifeTech Scientific Corporation Drug Eluting Coronary Stent System Product
 Table 124. LifeTech Scientific Corporation Recent Developments/Updates
 Table 125. MicroPort Scientific Corporation Company Information
 Table 126. MicroPort Scientific Corporation Description and Business Overview
 Table 127. MicroPort Scientific Corporation Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. MicroPort Scientific Corporation Drug Eluting Coronary Stent System Product
 Table 129. MicroPort Scientific Corporation Recent Developments/Updates
 Table 130. Yilson Medical Technology Company Information
 Table 131. Yilson Medical Technology Description and Business Overview
 Table 132. Yilson Medical Technology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Yilson Medical Technology Drug Eluting Coronary Stent System Product
 Table 134. Yilson Medical Technology Recent Developments/Updates
 Table 135. Lepu Medical Technology Company Information
 Table 136. Lepu Medical Technology Description and Business Overview
 Table 137. Lepu Medical Technology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Lepu Medical Technology Drug Eluting Coronary Stent System Product
 Table 139. Lepu Medical Technology Recent Developments/Updates
 Table 140. Shandong Hua'an Biotechnology Company Information
 Table 141. Shandong Hua'an Biotechnology Description and Business Overview
 Table 142. Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Shandong Hua'an Biotechnology Drug Eluting Coronary Stent System Product
 Table 144. Shandong Hua'an Biotechnology Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Drug Eluting Coronary Stent System Distributors List
 Table 148. Drug Eluting Coronary Stent System Customers List
 Table 149. Drug Eluting Coronary Stent System Market Trends
 Table 150. Drug Eluting Coronary Stent System Market Drivers
 Table 151. Drug Eluting Coronary Stent System Market Challenges
 Table 152. Drug Eluting Coronary Stent System Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Eluting Coronary Stent System
 Figure 2. Global Drug Eluting Coronary Stent System Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Drug Eluting Coronary Stent System Market Share by Type: 2025 & 2032
 Figure 4. Rapamycin Eluting Stent Product Picture
 Figure 5. Everolimus Eluting Stent Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Drug Eluting Coronary Stent System Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Drug Eluting Coronary Stent System Market Share by Application: 2025 & 2032
 Figure 9. Hospitals
 Figure 10. Clinic
 Figure 11. Others
 Figure 12. Global Drug Eluting Coronary Stent System Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Drug Eluting Coronary Stent System Market Size (US$ Million), 2021–2032
 Figure 14. Global Drug Eluting Coronary Stent System Sales (K Units), 2021–2032
 Figure 15. Global Drug Eluting Coronary Stent System Average Price (US$/Unit), 2021–2032
 Figure 16. Drug Eluting Coronary Stent System Report Years Considered
 Figure 17. Drug Eluting Coronary Stent System Sales Share by Manufacturers in 2025
 Figure 18. Global Drug Eluting Coronary Stent System Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Drug Eluting Coronary Stent System Players: Market Share by Revenue in Drug Eluting Coronary Stent System in 2025
 Figure 20. Drug Eluting Coronary Stent System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Drug Eluting Coronary Stent System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Drug Eluting Coronary Stent System Sales Market Share by Country (2021–2032)
 Figure 23. North America Drug Eluting Coronary Stent System Revenue Market Share by Country (2021–2032)
 Figure 24. United States Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Drug Eluting Coronary Stent System Sales Market Share by Country (2021–2032)
 Figure 27. Europe Drug Eluting Coronary Stent System Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Drug Eluting Coronary Stent System Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Drug Eluting Coronary Stent System Revenue Market Share by Region (2021–2032)
 Figure 35. China Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Drug Eluting Coronary Stent System Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Drug Eluting Coronary Stent System Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Drug Eluting Coronary Stent System Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Drug Eluting Coronary Stent System Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Drug Eluting Coronary Stent System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Drug Eluting Coronary Stent System by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Drug Eluting Coronary Stent System by Type (2021–2032)
 Figure 55. Global Drug Eluting Coronary Stent System Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Drug Eluting Coronary Stent System by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Drug Eluting Coronary Stent System by Application (2021–2032)
 Figure 58. Global Drug Eluting Coronary Stent System Price (US$/Unit) by Application (2021–2032)
 Figure 59. Drug Eluting Coronary Stent System Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI